| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38K | — | — |
| Cost of Revenue | $652K | — | — |
| Gross Profit | -$614K | — | — |
| R&D Expense | $631K | — | +3889.3% |
| SG&A Expense | $2.4M | — | +194.1% |
| Operating Income | -$3.6M | — | -340.0% |
| Pre-tax Income | -$3.7M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $386K | -57.2% | +549.6% |
| Accounts Receivable | $41K | +37.8% | — |
| Current Assets | $2.6M | -0.4% | -96.9% |
| Total Assets | $48.0M | -1.2% | -43.7% |
| Current Liabilities | $16.2M | +7.1% | -43.5% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | -118.3% |
| Financing Cash Flow | $1.5M | — | +107.7% |
| Income Tax | -$298K | — | — |
| Net Income | -$3.4M | — | -173.0% |
| EPS (Basic) | -$0.82 | — | -192.9% |
| EPS (Diluted) | -$0.82 | — | -192.9% |
| $20.5M |
| +3.8% |
| -28.8% |
| Stockholders' Equity | $23.6M | -5.4% | +552.4% |